U.S. Markets close in 3 hrs 21 mins
S&P 500
3,349.77+0.61(+0.02%)Nasdaq
11,069.35-38.72(-0.35%)Russell 2000
1,561.30+16.67(+1.08%)
Pfizer Inc. (PFE)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
38.49+0.22 (+0.56%)
As of 12:39PM EDT. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 38.27 |
| Open | 38.30 |
| Bid | 38.44 x 4000 |
| Ask | 38.45 x 2200 |
| Day's Range | 38.16 - 38.49 |
| 52 Week Range | 27.88 - 40.97 |
| Volume | 8,220,151 |
| Avg. Volume | 31,506,976 |
| Market Cap | 213.778B |
| Beta (5Y Monthly) | 0.73 |
| PE Ratio (TTM) | 15.24 |
| EPS (TTM) | 2.53 |
| Earnings Date | Oct 27, 2020 - Nov 02, 2020 |
| Forward Dividend & Yield | 1.52 (3.97%) |
| Ex-Dividend Date | Jul 30, 2020 |
| 1y Target Est | 41.85 |
- Editor's PickYahoo Finance
Coronavirus update: NY's Cuomo OKs sending students back to school as vaccine optimism rises
New York’s school districts will welcome students back into classrooms in the fall, Governor Andrew Cuomo announced on Friday, as the former coronavirus epicenter continues on its recovery.
- Editor's PickYahoo Finance Video
‘We need to make sure that the science and safety is there’ so people can trust the vaccine: doctor
The conversation around pricing vaccinations and distribution is ramping up as more pharmaceuticals announce positive test results. Dr. Rob Davidson, a West Michigan ER doctor and the Executive Director of the Committee to Protect Medicare, joins The Final Round panel to discuss his views on the coronavirus vaccine front.
- TheStreet.com
Pfizer to Produce Gilead Virus-Treatment Candidate Remdesivir
Pfizer signed a multi-year agreement to produce Gilead Sciences' coronavirus-treatment candidate remdesivir.
© 2020 Verizon Media. All rights reserved.
